STMNN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Organic Growth And GuidanceBroad regional growth and confirmed high single-digit organic guidance indicate continued demand for dental implants, orthodontics and digital workflows. This supports revenue visibility over the next several quarters and demonstrates resilient market positioning.
Digital And Implant Platform StrengthDouble-digit digital growth and strong iEXCEL adoption reinforce Straumann’s ecosystem of implants, scanners, software and consumables. Integrated workflows can increase customer retention, recurring revenue and cross-selling across dental practices.
Cash Generation And Balance SheetStrong free cash flow and a net cash position provide flexibility to fund innovation, capacity expansion, acquisitions and dividends without relying heavily on debt. This financial strength also improves resilience if dental demand or currencies weaken.
Bears Say
China Pricing And Regulatory RiskChina’s VBP 2.0 process could pressure implant pricing and profitability, while the market’s gradual recovery limits near-term growth visibility. Lower ASPs could also complicate Straumann’s premium positioning and require continued product or mix adaptation.
Tariff And Currency Margin PressureTariffs and unfavorable currency translation can weigh on reported margins even when underlying operations improve. Persistent exposure across manufacturing and international markets may require pricing actions, sourcing changes or productivity gains to protect profitability.
Profitability And Cash Conversion VolatilityThe prior deterioration in operating margins, earnings and cash conversion shows that revenue growth does not automatically translate into profit or cash. Cost pressure, investment and working-capital needs could limit sustained earnings quality despite the stronger latest half-year.
Straumann Holding AG News
STMNN FAQ
What was Straumann Holding AG’s price range in the past 12 months?
Currently, no data Available
What is Straumann Holding AG’s market cap?
Straumann Holding AG’s market cap is $311.71B.
When is Straumann Holding AG’s upcoming earnings report date?
Straumann Holding AG’s upcoming earnings report date is Oct 28, 2026 which is in 44 days.
How were Straumann Holding AG’s earnings last quarter?
Straumann Holding AG released its earnings results on Aug 19, 2026. The company reported $34.073 earnings per share for the quarter, beating the consensus estimate of $33.45 by $0.623.
Is Straumann Holding AG overvalued?
According to Wall Street analysts Straumann Holding AG’s price is currently Undervalued.
Does Straumann Holding AG pay dividends?
Straumann Holding AG does not currently pay dividends.
What is Straumann Holding AG’s EPS estimate?
Straumann Holding AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Straumann Holding AG have?
Straumann Holding AG has 159,455,250 shares outstanding.
What happened to Straumann Holding AG’s price movement after its last earnings report?
Straumann Holding AG reported an EPS of $34.073 in its last earnings report, beating expectations of $33.45. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Straumann Holding AG?
Currently, no hedge funds are holding shares in MX:STMNN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Straumann Holding AG
Straumann Holding AG is a global leader in providing advanced solutions for tooth replacement and orthodontic treatment. The company actively researches, develops, manufactures, and distributes a comprehensive range of dental products and services designed for tooth correction, restoration, replacement, and the prevention of tooth loss. Its extensive portfolio includes various dental implant systems (such as titanium, titanium alloy, ceramic, and mini implants), specialized surgical instruments, sophisticated CAD/CAM prosthetics, and the Clear Correct orthodontic aligners. Straumann also supplies vital biomaterials, including bone substitutes, membranes, and biologics, alongside cutting-edge digital tools like intraoral scanners, 3D printers, and milling machines for dental professionals and laboratories. Additionally, the company offers educational and training services to its customers. Straumann serves a diverse clientele, encompassing general dentists, specialists, dental technicians, laboratories, and institutional clients such as distributors, hospitals, and universities, reaching approximately 100 countries through its broad network of subsidiaries and partners. Established in 1954, Straumann Holding AG is headquartered in Basel, Switzerland.